Non-Hodgkin Lymphoma Presenting with Ophthalmoplegia and Gingival Pain
Hui Liang,Benyan Luo,Jinpeng Liu
DOI: https://doi.org/10.1097/01.wno.0000223271.78942.67
2006-01-01
Journal of Neuro-Ophthalmology
Abstract:We recently examined a Chinese patient with acute progressive ophthalmoplegia caused by non-Hodgkin lymphoma (NHL). A 51-year-old Chinese man had the sudden onset of double vision preceded by three days of left gingival pain. He reported no headache, fever, chills, nausea, vomiting, vertigo, or dizziness. His medical history included pancreatitis and type II diabetes. He was in no distress. Vital signs were normal. There was no meningismus, lymph node, spleen, or liver enlargement. The left mandibular gingiva was red and swollen. Neuro-ophthalmologic examination showed normal visual function. There was partial right upper lid ptosis. The right pupil measured 5 mm in dim illumination and reacted sluggishly to direct light. The left pupil measured 4 mm and reacted normally to direct light. There was no afferent pupillary defect. The right eye had 50% abduction, 60% adduction, and 50% vertical ductions. The ductions of the left eye were normal. Corneal sensation was intact bilaterally. All other aspects of the neurologic and ophthalmologic examinations were normal. Within five days of our initial examination, he had developed total absence of ductions of the right eye, complete right upper lid ptosis, and a 7 mm unreactive right pupil. A dentist diagnosed a left periodontal abscess and performed incision and drainage. The patient was treated with the antibiotic sulbactam/cefoperazone and intravenous insulin. Laboratory data disclosed a complete blood cell count of 6,500 white blood cells, 192,000 platelets, and a hemoglobin level of 13.7 g/dl. The erythrocyte sedimentation rate was elevated at 65 mm/h (normal, 2-20 mm/h), and the C-reactive protein level was elevated at 48 mg/l (normal, 0-8 mg/l). Standard blood chemistries, including renal and liver function studies, C3 and C4 complement, antinuclear antibody, anti-double-stranded DNA, and ELISA for HIV were negative. Orbit CT and brain MRI were also normal. Abdominal ultrasonography was normal. Lumbar puncture revealed a normal opening pressure, glucose, protein, cell count, and cytology. Fifteen days after admission, the patient noted bilateral edema of the legs with persistent complete right ophthalmoplegia, ptosis, and mydriasis. Over the next two days, blood creatinine level rose rapidly to 210 μmol/l (normal upper limit, 106) and BUN to 16.96 mmol/l (normal upper limit, 8.3). An abdominal CT scan demonstrated the presence of a soft tissue mass in the left perirenal space (Fig. 1). Ultrasound examination showed an enlarged spleen, liver, and kidneys (right kidney, 15 cm; left kidney, 16 cm) without signs of urinary obstruction. The kidney parenchyma was hypoechogenic; color-coded duplex sonography revealed no signs of renal artery or vein thrombosis.FIG. 1: CT abdominal imaging. Pre-contrast axial study shows a left pre-renal mass (arrow).Serial complete blood counts remained normal for the next 13 days. A second lumbar puncture performed seven days after presentation continued to show normal opening pressure, chemistries, cell count, and cytology. The patient refused renal biopsy, but incisional biopsy of the swollen gingiva demonstrated features of NHL with diffusely infiltrating tumor (Fig. 2A). Immunohistochemistry was strongly and diffusely positive for CD20 (Fig. 2B) and negative for CK, CL20, Syn, CyA, S-100, CD99, and CR 45RO. Bone marrow aspiration biopsy disclosed features of lymphoma.FIG. 2: Gingival biopsy. A. Diffuse infiltration of malignant lymphocytes (hematoxylin and eosin stain, ×400). B. Immunohistochemical staining shows that the tumor cells strongly express CD20, a marker for B cells (×400).With a diagnosis of stage IV B-cell NHL, the patient was treated with vincristine, adriamycin, and prednisone for one cycle, followed by cyclophosphamide, doxorubicin, vincristine, and prednisone as well as rituximab. He underwent daily hemodialysis during the systemic chemotherapy. After two weeks of chemotherapy, his right lid had opened halfway, and right eye ductions had all improved to 50% of normal. Leg edema was markedly improved as was renal function. Renal size had nearly normalized on ultrasound. The patient died of respiratory failure three months after starting treatment. An autopsy was not performed. NHL can affect cranial nerves by metastasis to the base of the skull. Depending on the location of the lesion, Greenberg et al (1) described five clinical syndromes: orbital, parasellar, middle fossa, jugular foramen, and occipital condyle. MRI can detect local deposits. Ophthalmoplegia occurs via leptomeningeal metastasis (2). Definitive diagnosis requires identification of malignant cells in the cerebrospinal fluid (CSF). The sensitivity of cytologic diagnosis with one CSF examination is 54% but increases to 91% with two lumbar punctures (3). Lau et al (4) have reported a patient with Burkitt lymphoma similar to our patient, in whom flow cytometric analysis of CSF with a normal cell count and cytology suggested the diagnosis of NHL (4). Our patient had no abnormalities on MRI or on two lumbar punctures. Ultrasonic visceral enlargement led to a suspicion of NHL that was confirmed on biopsy of the swollen gingiva. Aggressive chemotherapy rapidly resolved the ophthalmologic and renal manifestations. NHL commonly involves the oropharyngeal lymphoid tissue comprising Waldeyer's ring but only occasionally involves other oral tissues. Gingival inflammation may therefore be dismissed as a periodontal infection, as in our patient (5). Rituximab, the chimeric anti-CD20 monoclonal antibody, has been widely used in treatment of nearly all types of B-cell NHL. Clinical trials have attested to its efficacy when added during or after conventional chemotherapy (6,7). NHL should be added to the causes of rapidly progressive unilateral or bilateral ophthalmoplegia. Early chemotherapy may be curative. Hui Liang, MD Benyan Luo, MD Jinpeng Liu, MD The First Affiliated Hospital, School of Medicine, ZheJiang University, ZheJiang, China, [email protected]